Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Biometrical Journal. Biometrische Zeitschrift|January 26, 2019
Analysis of cause of death: Competing risks or progressive illness-death model?Michael Lauseker, Christine Zu Eulenburg
Journal of Clinical Epidemiology|February 25, 2026
Estimating Causal Effects on Quality of Life Under Treatment Discontinuation: The ALTA-1L TrialAmani Al Tawil, Michael Lauseker, Ulrich Mansmann
Biometrical Journal. Biometrische Zeitschrift|March 5, 2020
Estimating the distribution of heterogeneous treatment effects from treatment responses and from a predictive biomarker in a parallel-group RCT: A structural model approachRuediger P Laubender, Ulrich Mansmann, Michael Lauseker
Leukemia|April 15, 2025
Prognostic scoring systems in chronic myeloid leukaemiaMichael Lauseker, Verena S Hoffmann, Markus Pfirrmann
Journal of Cancer Research and Clinical Oncology|April 18, 2016
Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based studyMichael Lauseker, Roman Gerlach, Martin Tauscher, et al.
Blood|March 14, 2014
The impact of health care settings on survival time of patients with chronic myeloid leukemiaMichael Lauseker, Joerg Hasford, Markus Pfirrmann, et al.
Leukemia|September 19, 2023
Survival with chronic myeloid leukaemia after failing milestonesMichael Lauseker, Rüdiger Hehlmann, Andreas Hochhaus, et al.
Annals of Hematology|March 28, 2015
Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of deathMarkus Pfirrmann, Michael Lauseker, Verena S Hoffmann, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 23, 2021
Acute effects of spaced cathodal transcranial direct current stimulation in drug resistant focal epilepsiesElisabeth Kaufmann, Mirjam Hordt, Michael Lauseker, et al.
British Journal of Haematology|May 12, 2015
In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over timeMichael Lauseker, Jennifer Schemenau, Corinna Strupp, et al.
Pageof 8